Cargando…

Assessment of the potential for pathogen dispersal during high-flow nasal therapy

High-flow nasal therapy is increasingly used in hospitals because of its effectiveness and patient comfort. However, pathogens in the patient's nasal and oral cavities may be dispersed by forced air. This study aimed to investigate the risk of pathogen dispersal during high-flow nasal therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Kotoda, M., Hishiyama, S., Mitsui, K., Tanikawa, T., Morikawa, S., Takamino, A., Matsukawa, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Healthcare Infection Society. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114853/
https://www.ncbi.nlm.nih.gov/pubmed/31759093
http://dx.doi.org/10.1016/j.jhin.2019.11.010
_version_ 1783513975937302528
author Kotoda, M.
Hishiyama, S.
Mitsui, K.
Tanikawa, T.
Morikawa, S.
Takamino, A.
Matsukawa, T.
author_facet Kotoda, M.
Hishiyama, S.
Mitsui, K.
Tanikawa, T.
Morikawa, S.
Takamino, A.
Matsukawa, T.
author_sort Kotoda, M.
collection PubMed
description High-flow nasal therapy is increasingly used in hospitals because of its effectiveness and patient comfort. However, pathogens in the patient's nasal and oral cavities may be dispersed by forced air. This study aimed to investigate the risk of pathogen dispersal during high-flow nasal therapy. Liquid and bacterial dispersal were assessed via in-vitro experimental set-ups using a manikin. Thickened water or fresh yeast solution mimicked saliva and nasal mucus secretions. Dispersal was limited to the proximal area of the face and nasal cannula, suggesting that high-flow nasal therapy does not increase the risk of droplet and contact infection.
format Online
Article
Text
id pubmed-7114853
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Healthcare Infection Society. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71148532020-04-02 Assessment of the potential for pathogen dispersal during high-flow nasal therapy Kotoda, M. Hishiyama, S. Mitsui, K. Tanikawa, T. Morikawa, S. Takamino, A. Matsukawa, T. J Hosp Infect Article High-flow nasal therapy is increasingly used in hospitals because of its effectiveness and patient comfort. However, pathogens in the patient's nasal and oral cavities may be dispersed by forced air. This study aimed to investigate the risk of pathogen dispersal during high-flow nasal therapy. Liquid and bacterial dispersal were assessed via in-vitro experimental set-ups using a manikin. Thickened water or fresh yeast solution mimicked saliva and nasal mucus secretions. Dispersal was limited to the proximal area of the face and nasal cannula, suggesting that high-flow nasal therapy does not increase the risk of droplet and contact infection. The Healthcare Infection Society. Published by Elsevier Ltd. 2020-04 2019-11-20 /pmc/articles/PMC7114853/ /pubmed/31759093 http://dx.doi.org/10.1016/j.jhin.2019.11.010 Text en © 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kotoda, M.
Hishiyama, S.
Mitsui, K.
Tanikawa, T.
Morikawa, S.
Takamino, A.
Matsukawa, T.
Assessment of the potential for pathogen dispersal during high-flow nasal therapy
title Assessment of the potential for pathogen dispersal during high-flow nasal therapy
title_full Assessment of the potential for pathogen dispersal during high-flow nasal therapy
title_fullStr Assessment of the potential for pathogen dispersal during high-flow nasal therapy
title_full_unstemmed Assessment of the potential for pathogen dispersal during high-flow nasal therapy
title_short Assessment of the potential for pathogen dispersal during high-flow nasal therapy
title_sort assessment of the potential for pathogen dispersal during high-flow nasal therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114853/
https://www.ncbi.nlm.nih.gov/pubmed/31759093
http://dx.doi.org/10.1016/j.jhin.2019.11.010
work_keys_str_mv AT kotodam assessmentofthepotentialforpathogendispersalduringhighflownasaltherapy
AT hishiyamas assessmentofthepotentialforpathogendispersalduringhighflownasaltherapy
AT mitsuik assessmentofthepotentialforpathogendispersalduringhighflownasaltherapy
AT tanikawat assessmentofthepotentialforpathogendispersalduringhighflownasaltherapy
AT morikawas assessmentofthepotentialforpathogendispersalduringhighflownasaltherapy
AT takaminoa assessmentofthepotentialforpathogendispersalduringhighflownasaltherapy
AT matsukawat assessmentofthepotentialforpathogendispersalduringhighflownasaltherapy